Here’s what you should know:
1. In the fourth quarter of 2020, Motus GI reported a $4.4 million net loss, or a $0.12 loss per diluted share, up from a $5.9 million net loss during the same period in 2019.
2. The company reported about $20.8 million in cash and cash equivalents as of Dec. 31, 2020. That’s a 27.5 percent decrease compared to December 31, 2019.
3. The company saw fourth-quarter revenue of $36,000, which is a 63 percent decrease from the same period in 2019.
4. Motus GI attributed sales growth to disposable sleeve sales for its Pure-Vu System. The company also implemented a strategy to pursue reimbursement for the colonoscopy device.
5. Austin-based Dell Seton Medical Center at The University of Texas and New York City-based NYU Langone signed contracts with Motus GI for disposable sleeve purchase orders, effective for 2021.
6. Motus GI CEO Tim Moran said: “We reported a steady increase in commercial momentum during the second half of 2020 compared to the first half of the year. This momentum continued in the fourth quarter despite a resurgence of COVID-19 hospitalizations across much of the United States.”
More articles on physicians:
There were 226 ASCs opened in 2019 & 3 more MedPAC 2021 report highlights
Missouri medical group breaks ground on outpatient surgery center
Bundled payments in ASCs: Good business or a race to the bottom?
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
